Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan

• Κύριοι συγγραφείς: Motonobu Sakaguchi (Συγγραφέας), Shinji Takahashi (Συγγραφέας), Masahiko Kobayashi (Συγγραφέας), Tomomi Kimura (Συγγραφέας), Kazuhito Shiosakai (Συγγραφέας), Yasuaki Takeda (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2012-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

After the launch of dipeptidyl peptidase-4 (DPP-4), a new oral hypoglycemic drug (OHD), in December 2009, severe hypoglycemia cases were reported in Japan. Although the definite cause was unknown, co-administration with sulfonylureas (SU) was suspected as one of the potential risk factors. The Japan...